Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity-Reference-Cited by-同舟云学术

Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity

Published:2014-06-12 Issue:23 Volume:19 Page:
ISSN:1560-7917
Container-title:Eurosurveillance
language:en
Short-container-title:

Author:

Hemida M G¹²³,Perera R A⁴¹,Al Jassim R A⁵,Kayali G⁶,Siu L Y⁷,Wang P⁸⁷,Chu K W⁴,Perlman S⁹,Ali M A¹⁰,Alnaeem A¹¹,Guan Y⁴,Poon L L⁴,Saif L¹²,Peiris M⁷⁴

Affiliation:

1. These authors contributed equally to this work

2. Department of Virology Faculty of Veterinary Medicine, Kaferelsheik University, Egypt

3. Department of Microbiology and Parasitology, College of Veterinary Medicine, King Faisal University, Saudi Arabia

4. Centre of Influenza Research and School of Public Health, The University of Hong Kong, Hong Kong SAR, China

5. School of Agriculture and Food Sciences Faculty of Science, The University of Queensland, Gatton, Australia

6. St Jude Children’s Research Hospital, Memphis, TN, United States

7. HKU-Pasteur Pole, The University of Hong Kong, Hong Kong SAR, China

8. Key Laboratory of Protein and Peptide Pharmaceuticals, Chinese Academy of Sciences - University of Tokyo Joint Laboratory of Structural Virology and Immunology, Beijing, China

9. Department of Microbiology, University of Iowa, United States

10. Division of Environmental Research, National Research Centre, Giza, Egypt

11. Department of Clinical Studies, College of Veterinary Medicine, King Faisal University, Saudi Arabia

12. OARDC/The Ohio State University, Wooster, United States

Abstract

The pseudoparticle virus neutralisation test (ppNT) and a conventional microneutralisation (MN) assay are specific for detecting antibodies to Middle East respiratory syndrome coronavirus (MERS-CoV) when used in seroepidemiological studies in animals. Genetically diverse MERS-CoV appear antigenically similar in MN tests. We confirm that MERS-CoV was circulating in dromedaries in Saudi Arabia in 1993. Preliminary data suggest that feral Australian dromedaries may be free of MERS-CoV but larger confirmatory studies are needed.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

Reference22 articles.

1. World Health Organization (WHO). Middle East respiratory syndrome coronavirus (MERS-CoV) summary and literature update – as of 9 May 2014. Geneva:WHO. [Accessed 30 May 2014]. Available from: http://www.who.int/csr/disease/coronavirus_infections/MERS_CoV_Update_09_May_2014.pdf

2. Epidemiologic Clues to SARS Origin in China

3. One Health: The Hong Kong Experience with Avian Influenza

4. Severe acute respiratory syndrome

5. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and preliminary validation of a MERS-CoV ELISA for serological testing of camels and alpacas;Journal of Virological Methods;2024-06

2. Influenza D in Domestic and Wild Animals;Viruses;2023-12-15

3. MERS-CoV seroconversion amongst Malaysian Hajj pilgrims returning from the Middle East, 2016–2018: results from the MERCURIAL multiyear prospective cohort study;Emerging Microbes & Infections;2023-05-23

4. Unravelling Antigenic Cross-Reactions toward the World of Coronaviruses: Extent of the Stability of Shared Epitopes and SARS-CoV-2 Anti-Spike Cross-Neutralizing Antibodies;Pathogens;2023-05-13

5. Detection of Middle East Respiratory Syndrome Coronavirus-Specific RNA and Anti-MERS-Receptor-Binding Domain Antibodies in Camel Milk from Different Regions of Saudi Arabia;Viral Immunology;2022-12-01